Asia-Pacific Lung Cancer Diagnostic Tests Market Report 2017




In this report, the Asia-Pacific Lung Cancer Diagnostic Tests market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Lung Cancer Diagnostic Tests for these regions, from 2012 to 2022 (forecast), including China Japan South Korea Taiwan India Southeast Asia Australia Asia-Pacific Lung Cancer Diagnostic Tests market competition by top manufacturers/players, with Lung Cancer Diagnostic Tests sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Advpharma Inc AIT Austrian Institute of Technology GmbH Courtagen Life Sciences Inc DiagnoCure Inc. (Inactive) BioMark Diagnostics Inc. BioMarker Strategies LLC Emory University Epigenomics AG GlycoZym HalioDx SAS Louisville Bioscience, Inc. Mayo Clinic US On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into Immunoassays Flow Cytometry Rapid Tests Molecular Assays Tissue Arrays Circulating Tumor Cells Pharmacodiagnostics Biomarkers Other Diagnostics Methods On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Precision Medicine Personalized Medicine Cancer Monitoring If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

Asia-Pacific Lung Cancer Diagnostic Tests Market Report 2017
1 Lung Cancer Diagnostic Tests Overview
    1.1 Product Overview and Scope of Lung Cancer Diagnostic Tests
    1.2 Classification of Lung Cancer Diagnostic Tests by Product Category
        1.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Immunoassays
        1.2.4 Flow Cytometry
        1.2.5 Rapid Tests
        1.2.6 Molecular Assays
        1.2.7 Tissue Arrays
        1.2.8 Circulating Tumor Cells
        1.2.9 Pharmacodiagnostics
        1.2.10 Biomarkers
        1.2.11 Other Diagnostics Methods
    1.3 Asia-Pacific Lung Cancer Diagnostic Tests Market by Application/End Users
        1.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Precision Medicine
        1.3.3 Personalized Medicine
        1.3.4 Cancer Monitoring
    1.4 Asia-Pacific Lung Cancer Diagnostic Tests Market by Region
        1.4.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Lung Cancer Diagnostic Tests (2012-2022)
        1.5.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Lung Cancer Diagnostic Tests Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Lung Cancer Diagnostic Tests Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Lung Cancer Diagnostic Tests (Volume and Value) by Type
        2.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Lung Cancer Diagnostic Tests (Volume) by Application
    2.4 Asia-Pacific Lung Cancer Diagnostic Tests (Volume and Value) by Region
        2.4.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Market Share by Region (2012-2017)

3 China Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    3.1 China Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        3.1.1 China Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        3.1.3 China Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    3.2 China Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    3.3 China Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

4 Japan Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    4.1 Japan Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        4.1.1 Japan Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    4.2 Japan Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    4.3 Japan Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

5 South Korea Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    5.1 South Korea Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        5.1.1 South Korea Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    5.2 South Korea Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    5.3 South Korea Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

6 Taiwan Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    6.1 Taiwan Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        6.1.1 Taiwan Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    6.2 Taiwan Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    6.3 Taiwan Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

7 India Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    7.1 India Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        7.1.1 India Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        7.1.3 India Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    7.2 India Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    7.3 India Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

8 Southeast Asia Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    8.1 Southeast Asia Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        8.1.1 Southeast Asia Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    8.2 Southeast Asia Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    8.3 Southeast Asia Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

9 Australia Lung Cancer Diagnostic Tests (Volume, Value and Sales Price)
    9.1 Australia Lung Cancer Diagnostic Tests Sales and Value (2012-2017)
        9.1.1 Australia Lung Cancer Diagnostic Tests Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Lung Cancer Diagnostic Tests Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Lung Cancer Diagnostic Tests Sales Price Trend (2012-2017)
    9.2 Australia Lung Cancer Diagnostic Tests Sales Volume and Market Share by Type
    9.3 Australia Lung Cancer Diagnostic Tests Sales Volume and Market Share by Application

10 Asia-Pacific Lung Cancer Diagnostic Tests Players/Suppliers Profiles and Sales Data
    10.1 Advpharma Inc
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 AIT Austrian Institute of Technology GmbH
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Courtagen Life Sciences Inc
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 DiagnoCure Inc. (Inactive)
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 BioMark Diagnostics Inc.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 BioMarker Strategies LLC
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Emory University
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Emory University Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Epigenomics AG
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 GlycoZym
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 GlycoZym Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 HalioDx SAS
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Lung Cancer Diagnostic Tests Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Louisville Bioscience, Inc.
    10.12 Mayo Clinic US

11 Lung Cancer Diagnostic Tests Manufacturing Cost Analysis
    11.1 Lung Cancer Diagnostic Tests Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Lung Cancer Diagnostic Tests

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Lung Cancer Diagnostic Tests Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Lung Cancer Diagnostic Tests Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Lung Cancer Diagnostic Tests Market Forecast (2017-2022)
    15.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Lung Cancer Diagnostic Tests Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Lung Cancer Diagnostic Tests Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Lung Cancer Diagnostic Tests Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Lung Cancer Diagnostic Tests Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Lung Cancer Diagnostic Tests Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Lung Cancer Diagnostic Tests Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Lung Cancer Diagnostic Tests Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer



List of Tables and Figures

    Figure Product Picture of Lung Cancer Diagnostic Tests
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2022)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (Product Category) in 2016
    Figure Immunoassays Product Picture
    Figure Flow Cytometry Product Picture
    Figure Rapid Tests Product Picture
    Figure Molecular Assays Product Picture
    Figure Tissue Arrays Product Picture
    Figure Circulating Tumor Cells Product Picture
    Figure Pharmacodiagnostics Product Picture
    Figure Biomarkers Product Picture
    Figure Other Diagnostics Methods Product Picture
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales (K Units) by Application (2012-2022)
    Figure Asia-Pacific Sales Market Share of Lung Cancer Diagnostic Tests by Application in 2016
    Figure Precision Medicine Examples
    Table Key Downstream Customer in Precision Medicine
    Figure Personalized Medicine Examples
    Table Key Downstream Customer in Personalized Medicine
    Figure Cancer Monitoring Examples
    Table Key Downstream Customer in Cancer Monitoring
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Market Size (Million USD) by Region (2012-2022)
    Figure China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Japan Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure South Korea Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Taiwan Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure India Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southeast Asia Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Australia Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume (K Units) and Growth Rate (2012-2022)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Market Major Players Product Sales Volume (K Units)(2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales (K Units) of Key Players/Suppliers (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Lung Cancer Diagnostic Tests Sales Share by Players/Suppliers
    Figure 2017 Asia-Pacific Lung Cancer Diagnostic Tests Sales Share by Players/Suppliers
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Market Major Players Product Revenue (Million USD) 2012-2017
    Table Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 Asia-Pacific Lung Cancer Diagnostic Tests Revenue Share by Players
    Figure 2017 Asia-Pacific Lung Cancer Diagnostic Tests Revenue Share by Players
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales and Market Share by Type (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales Share by Type (2012-2017)
    Figure Sales Market Share of Lung Cancer Diagnostic Tests by Type (2012-2017)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Growth Rate by Type (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Type (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Lung Cancer Diagnostic Tests by Type (2012-2017)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Revenue Growth Rate by Type (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume (K Units) and Market Share by Region (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales Share by Region (2012-2017)
    Figure Sales Market Share of Lung Cancer Diagnostic Tests by Region (2012-2017)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Market Share by Region in 2016
    Table Asia-Pacific Lung Cancer Diagnostic Tests Revenue (Million USD) and Market Share by Region (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Revenue Share (%) by Region (2012-2017)
    Figure Revenue Market Share of Lung Cancer Diagnostic Tests by Region (2012-2017)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Revenue Market Share by Region in 2016
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales Volume (K Units) and Market Share by Application (2012-2017)
    Table Asia-Pacific Lung Cancer Diagnostic Tests Sales Share (%) by Application (2012-2017)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Market Share by Application (2012-2017)
    Figure Asia-Pacific Lung Cancer Diagnostic Tests Sales Market Share by Application (2012-2017)
    Figure China Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure China Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure China Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table China Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table China Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure China Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table China Lung Cancer Diagnostic Tests Sales Volume (K Units) by Applications (2012-2017)
    Table China Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure China Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Figure Japan Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure Japan Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Japan Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table Japan Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table Japan Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure Japan Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table Japan Lung Cancer Diagnostic Tests Sales Volume (K Units) by Applications (2012-2017)
    Table Japan Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure Japan Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Figure South Korea Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure South Korea Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure South Korea Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table South Korea Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table South Korea Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure South Korea Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table South Korea Lung Cancer Diagnostic Tests Sales Volume (K Units) by Applications (2012-2017)
    Table South Korea Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure South Korea Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Figure Taiwan Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure Taiwan Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Taiwan Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table Taiwan Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table Taiwan Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure Taiwan Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table Taiwan Lung Cancer Diagnostic Tests Sales Volume (K Units) by Applications (2012-2017)
    Table Taiwan Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure Taiwan Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Figure India Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure India Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure India Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table India Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table India Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure India Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table India Lung Cancer Diagnostic Tests Sales Volume (K Units) by Application (2012-2017)
    Table India Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure India Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Figure Southeast Asia Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure Southeast Asia Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Southeast Asia Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table Southeast Asia Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table Southeast Asia Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure Southeast Asia Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table Southeast Asia Lung Cancer Diagnostic Tests Sales Volume (K Units) by Applications (2012-2017)
    Table Southeast Asia Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure Southeast Asia Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Figure Australia Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure Australia Lung Cancer Diagnostic Tests Revenue (Million USD) and Growth Rate (2012-2017)
    Figure Australia Lung Cancer Diagnostic Tests Sales Price (USD/Unit) Trend (2012-2017)
    Table Australia Lung Cancer Diagnostic Tests Sales Volume (K Units) by Type (2012-2017)
    Table Australia Lung Cancer Diagnostic Tests Sales Volume Market Share by Type (2012-2017)
    Figure Australia Lung Cancer Diagnostic Tests Sales Volume Market Share by Type in 2016
    Table Australia Lung Cancer Diagnostic Tests Sales Volume (K Units) by Applications (2012-2017)
    Table Australia Lung Cancer Diagnostic Tests Sales Volume Market Share by Application (2012-2017)
    Figure Australia Lung Cancer Diagnostic Tests Sales Volume Market Share by Application in 2016
    Table Advpharma Inc Lung Cancer Diagnostic Tests Basic Information List
    Table Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure Advpharma Inc Lung Cancer Diagnostic Tests Sales Market Share in Asia-Pacific (2012-2017)
    Figure Advpharma Inc Lung Cancer Diagnostic Tests Revenue Market Share in Asia-Pacific (2012-2017)
    Table AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Basic Information List
    Table AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Sales Market Share in Asia-Pacific (2012-2017)
    Figure AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue Market Share in Asia-Pacific (2012-2017)
    Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Basic Information List
    Table Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Sales Market Share in Asia-Pacific (2012-2017)
    Figure Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue Market Share in Asia-Pacific (2012-2017)
    Table DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Basic Information List
    Table DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Sales Market Share in Asia-Pacific (2012-2017)
    Figure DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue Market Share in Asia-Pacific (2012-2017)
    Table BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Basic Information List
    Table BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Sales Market Share in Asia-Pacific (2012-2017)
    Figure BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue Market Share in Asia-Pacific (2012-2017)
    Table BioMarker Strategies LLC Lung Cancer Diagnostic Tests Basic Information List
    Table BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales (K Units) and Growth Rate (2012-2017)
    Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Sales Market Share in Asia-Pacific (2012-2017)
    Figure BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue Market Share in Asia-Pacific (2012-2017)
    Table Emory University Lung Cancer Diagnostic Tests Basic Information List
    Table Emory University Lung Cancer Diagnostic Tests Sales (K Units)

Let our analyst help you with a customized solution for your market research needs

Select the license

Credit card Logo
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
Discount  Check Discount Question  Any Questions
hkjkhjkhjkhjkmjhjhkhjkjkhjkhjkm
fgfhfhfgf